|
Harrison's Principles of Internal Medicine, 18e
6/8/2012: A Risk Stratification System for the Development of Natalizumab-Associated PML in Multiple Sclerosis Patients
S. Andrew Josephson
M.D., Department of Neurology, University of California San Francisco, San Francisco, USA
Topics Discussed: adverse effects of medication; demyelinating disease; drug therapy problems and resolution (e.g., duplication, dosage, drug interactions, adverse drug reactions and interactions, frequency, dosage form, indication mismatches); jc virus; multiple sclerosis; natalizumab; progressive multifocal leukoencephalopathy; stratification.
Related to Harrison's Chapter 380. Multiple Sclerosis and Other Demyelinating Diseases; View in chapter;
Excerpt:"View in chapter..."
The content above is only an excerpt.
For full access, log into an existing user account below,
purchase an annual subscription, or
purchase a short-term subscription to the complete website.
|
|
|
|
Or
|
|
|
|